Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer | MicrobiomeTrials← Back to trialsNCT01174121
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2010-08-26Est. Completion: 2028-12-27
Enrollment target: 332 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Colorectal NeoplasmsNeoplasmsIntrahepatic CholangiocarcinomaAdrenocortical CarcinomaMetastasis, Neoplasm
Background:
Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …
Bethesda, United StatesEst. completion Dec 31, 2029
Colorectal NeoplasmsGastric NeoplasmsCholangiocarcinomaBile Duct CancerPancreas Cancer
Background:
\- Recent advances in cancer research have led to new therapies to treat the disease. It is important to co…
Bethesda, United StatesEst. completion Jun 30, 2035
Breast NeoplasmsColorectal NeoplasmsProstate NeoplasmEndometrial NeoplasmsNeoplasm MetastasisStomach NeoplasmsEsophageal Neoplasms
The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relev…
Duarte, United StatesEst. completion Apr 2030